Skip to main content
Premium Trial:

Request an Annual Quote

Bristol-Myers Squibb Licenses GeneGo's Software and Databases

NEW YORK (GenomeWeb News) - Bristol-Myers Squibb has licensed GeneGo’s software and database platforms for its pharmaceutical research programs, GeneGo said today.
 
Under the multi-year agreement, BMS will use "all major GeneGo products" for chemical and biological studies, GeneGo said. BMS researchers will use the company’s tools to analyze data and to build their own pathway maps using public, GeneGo, and proprietary data.
 
GeneGo said that BMS researchers will also use its products to overlay in-house interaction data over the company’s manually curated pathways.
 
GeneGo's software suite includes MetaCore, which is used to target and identify biomarkers for disease research; the MetaDrug platform, for studying metabolism and toxicity; and MetaBase, which holds data and information for the MetaCore product.
 
Financial terms of the agreement were not released.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.